Interesting, after calculating the comprehensive signature of KRT6A and S100A2 in CRC tissues (including colon adenocarcinoma and rectum adenocarcinoma), we found that the signature score derived from KRT6A and S100A2 was higher in CRC tissues compared non-tumor tissues (Figure 5m). The gene discussed is S100A2; the disease is neoplasm.